CNS adverse effects of nonsteroidal anti-inflammatory drugs: Therapeutic implications

CNS Drugs

Volumn 9, Issue 4, 1998, Pages 281-290

  Morgan, Althea ^a   Clark, David ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOBENZAPRINE; FENOPROFEN; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; TOLMETIN;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; ASEPTIC MENINGITIS; CELLULAR IMMUNITY; COGNITIVE DEFECT; CONFUSION; DRUG CROSS TOLERANCE; DRUG EFFECT; DRUG INDUCED DISEASE; HEADACHE; HEARING IMPAIRMENT; HUMAN; MENTAL DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TINNITUS; VERTIGO;

EID: 0031953819     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199809040-00004     Document Type: Article

References (53)

1. Hoppmann RA, Peden JG, Ober SK. Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Arch Intern Med 1991; 151: 1309-13
2. Clark DWJ, Ghose K. Neuropsychiatric reactions to nonsteroidal anti-inflammatory drugs. Drug Saf 1992; 7 (6): 460-5
3. Figueras A, Capella D, Castel JM, et al. Spontaneous reporting of adverse drug reactions to nonsteroidal anti-inflammatory drugs: a report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations. Eur J Clin Pharmacol 1994; 47 (4): 297-303
4. Widener HL, Littman BH. Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA 1978; 239 (11): 1062-4
5. Marinac JS. Drug- and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother 1992; 26: 813-22
6. Giansiracusa DF, Blumberg S, Kantrowitz FG. Aseptic meningitis associated with ibuprofen. Arch Intern Med 1980; 140: 1553
7. Wasner CK. Ibuprofen, meningitis, and systemic lupus erythematosus. J Rheum 1987; 5: 162-4
8. Samuelson Jr CO, Williams HJ. Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. West J Med 1979; 131: 57-9
9. Ruppert GB, Barth WF. Ibuprofen hypersensitivity in systemic lupus erythematosus. South J Med 1981; 74: 241-3
10. Gilbert GJ, Eichenbaum HW. Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. South J Med 1989; 82: 514-5
11. Mandell BF, Raps EC. Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. Am J Med Sci 1987; 82: 817-20
12. Jensen S, Glud TK, Bacher T, et al. Ibuprofen-induced meningitis in a male with systemic lupus erythematosus. Acta Med Scand 1987; 221: 509-11
13. Katona BG, Wigley FM, Walters JK, et al. Aseptic meningitis from over-the-counter ibuprofen. Lancet 1988; I: 59
14. Peck MG, Joyner PU. Ibuprofen-associated aseptic meningitis. Clin Pharm 1982; 1: 561-5
15. Bernstein RF. Ibuprofen-related meningitis in mixed connective tissue disease. Ann Intern Med 1980; 92: 206-7
16. Hoffman M, Gray RG. Ibuprofen-induced meningitis in mixed connective tissue disease. Clin Rheumatol 1982; 1: 128-30
17. Perera DR, Seiffert AK, Greeley HM. Ibuprofen and meningo-encephalitis. Ann Inter Med 1984; 100: 619
18. Bouland DL, Specht NL, Hegstad DG. Ibuprofen and aseptic meningitis. Ann Inter Med 1986; 104: 731
19. Lawson JM, Grady MJ. Ibuprofen-induced aseptic meningitis in a previously healthy patient. West J Med 1985; 143: 386-7
20. Ewert BH. Ibuprofen-associated meningitis in a woman with only serological evidence of a rheumatological disorder. Am J Med Sci 1989; 297: 326-7
21. Quinn JP, Weinstein RA, Caplan LR. Eosinophilic meningitis and ibuprofen therapy. Neurology 1984; 34: 108-9
22. Ballas ZK, Donta ST. Sulindac-induced aseptic meningitis. Arch Intern Med 1982; 142: 165-6
23. Von Reyn CF. Recurrent aseptic meningitis due to sulindac. Ann Intern Med 1983; 99: 343-4
24. Greenberg GN. Recurrent sulindac-induced aseptic meningitis in a patient tolerant to other nonsteroidal anti-inflammatory drugs. South Med J 1988; 81: 1463-4
25. Neufeld MY, Korezyn AD. Encephalopathy associated with sulindac. Hum Toxicol 1986; 5: 55
26. Yasuda U, Akiguchi I, Kameyama M. Sulindac-induced aseptic meningitis in mixed connective tissue disease. Clin Neurol Neurosurg 1989; 91: 257-60
27. Sylvia LM, Forlenza SW, Brocavich JM. Aseptic meningitis associated with naproxen [letter]. Drug Intell Clin Pharm 1988; 22: 399-401
28. Weksler BB, Lehany AM. Naproxen-induced recurrent aseptic meningitis. Drug Intell Clin Pharm 1991; 25: 1183-4
29. Ruppert GB, Barth WF. Tolmetin-induced aseptic meningitis. JAMA 1981; 245 (1): 67-8
30. Schoenfeld Y, Livni E, Shakli M, et al. Sensitisation to ibuprofen in systemic lupus erythematosus [letter]. JAMA 1980; 244 (6): 547-8
31. 1 mice. Arthritis Rheum 1985; 28 (1): 104-7
32. Canoso J, Cohen A. Aseptic meningitis in systematic lupus erythematosus. Arthritis Rheum 1975; 18: 369-74
33. Finch WR, Strottman MP. Acute adverse reactions to ibuprofen in systemic lupus erythematosus. JAMA 1979; 241 (24): 2616-8
34. Garugusi V, Neefe L, Mann O. Acute meningoencephalitis associated with isoniazid administration. JAMA 1976; 235: 1141-2
35. Kremer I, Ritz R, Brunner F. Aseptic meningitis as an adverse effect of cotrimoxazole. N Engl J Med 1983; 308: 1481
36. Chez M, Sila CA, Ransohoff RM, et al. Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. Neurology 1989; 39: 1578-80
37. Singh G, Mamey DR, Morfeld D, et al. Comparative toxicity of nonsteroidal anti-inflammatory agents. Pharmacol Ther 1994; 62: 175-91
38. Weinblatt ME. Nonsteroidal anti-inflammatory drug toxicity: increased risk in the elderly. Scand J Rheumatol 1991; Suppl. 91: 9-17
39. Day RO, Graham GG, Bieri D, et al. Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers. Br J Clin Pharmacol 1989; 28: 695-702
40. Furst DE. Toxicity of antirheumatic medications in children with juvenile arthritis. J Rheumatol 1992; 19 Suppl. 33: 11-5
41. Browning CH. Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. Int J Psychiatry Med 1996; 26 (1): 25-34
42. Telekes A, Holland RL, Peck AW. Indomethacin: effects on cold-induced pain and the nervous system in healthy volunteers. Pain 1987; 30 (3): 321-8
43. O'Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal antiinflammatory drugs. J Rheumatol 1985; 12 (4): 785-90
44. Gotz V. Paranoid psychosis with indomethacin [letter]. BMJ 1978; 1: 49
45. Goodwin JS, Regan M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum 1982; 25: 1013-5
46. Wysenbeck AJ, Klein Z, Mane R. Assessment of cognitive function in elderly patients treated with naproxen: a prospective study. Clin Exp Rheumatol 1988; 6 (4): 399-400
47. Bruce-Jones PNE, Crome P, Kalra L. Indomethacin and cognitive function in healthy elderly volunteers. Br J Clin Pharmacol 1994; 38: 45-51
48. Andersen K, Launer LJ, Ott A, et al. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995; 45 (8): 1441-5
49. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996; 47 (2): 425-32
50. Stewart WF, Kawas C, Corrada M, et al. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997; 48 (3): 626-32
51. Netter P, Lapicque F, Bannwarth B, et al. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid [letter]. Eur J Clin Pharmacol 1985; 29: 319
52. Bannwarth B, Netter P, Pourel J, et al. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomed Pharmacother 1989; 43: 121-6
53. Bannwarth B, Lapicque F, Pehourcq F, et al. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol 1995; 40: 266-9